Thomas Lingelbach's guest appearances

Thomas Lingelbach

Empowered Patient Podcast

Outbreak News Interviews

Mary Millard

Mark Allen

Bernie Sanders

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

OwlTail

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs.  This biotech company is in development of a Lyme disease vaccine and vaccines for mosquito-borne illnesses such as Zika and chikungunya. Thomas talks about the challenges of testing vaccines to prevent a disease within a healthy population and why it is impossible to eliminate all the vectors that can transmit a disease. @ValnevaSE #Lyme #LymeDisease  #chikungunya Valneva.com Download the transcript here Additional links: Chikungunya Fact Sheet Lyme Fact Sheet World Health Organization Zika virus resources World Health Organization Japanese encephalitis resources

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs.  This biotech company is in development of a Lyme disease vaccine and vaccines for mosquito-borne illnesses such as Zika and chikungunya. Thomas talks about the challenges of testing vaccines to prevent a disease within a healthy population and why it is impossible to eliminate all the vectors that can transmit a disease. @ValnevaSE #Lyme #LymeDisease  #chikungunya <a href="http://valneva.com" rel="noopener nofollow" target="_blank">Valneva.com</a> <a href="http://empoweredpatientradio.com/developing-preventative-vaccines-for-infectious-diseases-with-thomas-lingelbach-valneva-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a> Additional links: <a href="https://valneva.com/wp-content/uploads/2019/08/Chik-Fact-Sheet_VLA_2019_0805.pdf" rel="noopener nofollow" target="_blank">Chikungunya Fact Sheet</a> <a href="https://valneva.com/wp-content/uploads/2019/08/Lyme-Disease-Fact-Sheet_VLA_2019_0805-6.pdf" rel="noopener nofollow" target="_blank">Lyme Fact Sheet</a> <a href="https://www.who.int/news-room/fact-sheets/detail/zika-virus" rel="noopener nofollow" target="_blank">World Health Organization Zika virus resources</a> <a href="https://www.who.int/news-room/fact-sheets/detail/japanese-encephalitis" rel="noopener nofollow" target="_blank">World Health Organization Japanese encephalitis resources</a>

Developing Preventative Vaccines for Infectious Diseases with Thomas Lingelbach Valneva

The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates–the mosquito borne virus, chikungunya and Lyme disease. On today’s show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates. Related:  Neglected Tropical Diseases: Chagas disease and schistosomiasis  Lyme bacteria […] The post Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach appeared first on Outbreak News Today.

The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates–the mosquito borne virus, chikungunya and Lyme disease. On today’s show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates. Related:  Neglected Tropical Diseases: Chagas disease and schistosomiasis  Lyme bacteria […] The post <a href="https://outbreaknewstoday.com/chikungunya-and-lyme-vaccine-candidates-with-valneva-ceo-thomas-lingelbach-50815/" rel="nofollow" target="_blank">Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach</a> appeared first on <a href="https://outbreaknewstoday.com" rel="nofollow" target="_blank">Outbreak News Today</a>.

Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach